The tumour used was a syngeneic adenocarcinoma which arose spontaneously as a mammary tumour in a virgin female mouse, and which was obtained originally from Dr D. Trevan, Imperial Cancer Research Fund, London. Transplantation was carried out using cell suspensions obtained from 10-day solid subcutaneous tumours, and 106 viable cells were injected s.c. in the dorsolumbar region.
A formalin-killed suspension of C. parvum (Strain Number CN 6134, Batch BA 3935/A) was a gift from Wellcome Research Laboratories, Beckenham, Kent, and contained 7 mg dry wt/ml. Animals were injected i.p. with 1-4 mg at the same time as tumour-cell injection. Iota carrageenan (Auby Gel x52, Lot 1557) was prepared and injected as described previously (Thomson & Fowler, 1977 Treatment of mice with C. parvum and iota carrageenan had marked but opposing effects on tumout growth (Fig. 1) . Injection of C. parvuim impaired growth, whereas pretreatment with carrageenan potentiated growth of the tumour. Evidence that both these agents affected activity of the reticuloendothelial system was clearly demonstrated by increases in sDleen weioht ahove those in t1iimcmr-
bearing controls (Fig. 2) Our results clearly demonstrate that C. parvum and carrageenan exert opposing effects on growth of a transplantable tumour within syngeneic hosts, and are consistent with the reported antagonistic effect of carrageenan and other antimacrophage agents on the anti-tumour activity of microbial adjuvants (Hopper et al., 1976; Keller, 1977) .
Although splenomegaly is an overt manifestation of the reticuloendothelialstimulating properties of C. parvum, the significant increase in spleen weight induced by carrageenan is also accompanied by a relative increase in phagocyte activity within this organ, with a concomitant decrease in activity of the liver (Fowler & Thomson, 1978) . However, it is clear from this study that although increased spleen weight accompanies the arrest of tumour growth in the case of C. parvum, the inverse correlation exists for carrageenan treatment. This implies that the systemic effects of these agents may be of greater relevance to tumour growth than their influences on the spleen alone.
The low incidence of Fe-receptor-positive and phagocyte cells within tumours in this study is consistent with the scarcity of histologically recognizable lymphoreticular cells within this particular tumour (Thomson et al., unpublished) .
Comparable proportions of cells with functional macrophage characteristics have been found within certain other animal tumours, although considerably higher incidences have been reported both in animal and human tumours (Evans, 1972; Eccles & Alexander, 1974a, b; Russell et al., 1976; Wood & Gollahon, 1977) . The decline in the proportion of Fcreceptor-bearing cells with increased tumour size observed in the present study is consistent with work on other tumours by Szymaniec & James (1976) and Moore & Moore (1977) . Fc-receptor-bearing cells within tumours may constitute a heterogeneous population, since a variety of cells, other than macrophages, including B or T lymphocytes, neutrophils, eosinophils and mast cells may display this characteristic (see Korn et al., 1978) . The relatively higher incidence of Fc-receptor-positive over carbon-ingesting cells, which we have observed, may be explained by the presence of non-phagocytic monocytes, such as those described by Haskill et al. (1976) . In the latter study these cells constituted the major effector-cell population, and it is monocytes rather than mature macrophages which would be increased by C. parvum.
It is difficult to reconcile the welldocumented effects of C. parvum and carrageenan on macrophage activity in vivo with their failure to influence more markedly the incidence of cells with macrophage characteristics within the tumour, particularly in view of the pronounced effects of these agents on tumour growth. However, Szymaniec & James (1976) found that C. parvum occasionally had an appreciable antitumour effect without increasing the proportion of Fcreceptor-positive cells within the tumour. In contrast, Eccles & Alexander (1974a) showed that BCG induced a small decrease in metastasis which was associated with a slight increase in tumour macrophages. We are aware of no studies other than the present one on the effect of carrageenan on the macrophage content of experimental tumours. Although our study is based on observations on only one tumour model, it is clear that the marked effects of C. parvum and carrageenan on reticuloendothelial function in vivo are not necessarily reflected in similarly pronounced alteration in the proportion of cells with functional macrophage characteristics within solid tumours. Further studies in progress with C. parvum and carrageenan, aimed at analysing the initial interactions between host lymphoreticular and tumour cells, may help resolve this apparently paradoxical situation.
